Cansino Biologics
World Rank (Aug-2026)
6,702
Market Cap (Aug-2026)
1.814 Billion USD
World Rank (Jan-05-2024)
6,715
Market Cap (Jan-05-2024)
1.516 Billion USD
World Rank (Jul-30-2023)
5,684
Market Cap (Jul-30-2023)
2.030 Billion USD
World Rank (Dec-25-2022)
3,500
Market Cap (Dec-25-2022)
3.702 Billion USD
World Rank (Jan-07-2022)
2,240
Market Cap (Jan-07-2022)
8.02 Billion USD
Annual Revenue in USD
675 Million USD
Annual Net Income in USD
300 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
CanSino Biologics is an Innovative Biopharmaceutical company. It is currently developing 16 vaccine candidates for 13 infectious disease areas, preventing meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, pertussis, diphtheria, tetanus, shingles etc. The headquarters is in China.
Company Website